CN2 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Catalyst Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 26.4 EUR

Market Cap: €1.2B

C	Catalyst Pharmaceuticals Inc SWB:CN2	US
C	China Fineblanking Technology Co Ltd TPEX:1586	TW
	Black Pearl SA F:7ZX	PL
	INV Inc TSE:7338	JP
B	Bayhorse Silver Inc XMUN:7KXN	CA
S	Scienjoy Holding Corp NASDAQ:SJ	CN
I	International Iconic Gold Exploration Corp OTC:MFMLF	CA
	Caeneus Minerals Ltd ASX:CAD	AU
R	Ridgefield Acquisition Corp OTC:RDGA	US
T	Tinka Resources Ltd F:TLD	CA
	Canadian Premium Sand Inc XTSX:CPS	CA
	Sakae Electronics Corp TSE:7567	JP
B	Batero Gold Corp OTC:BELDF	CA
A	Africa Energy Corp XMUN:H73	CA
	Methanex Corp TSX:MX	CA
	Bankwell Financial Group Inc F:33W	US

Profitability Summary

Catalyst Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

86%

Gross Margin is Increasing

86% > 86%

Exceptional Operating Margin

45%

Strong 3Y Average Operating Margin

35%

Declining Operating Margin

46% > 45%

Exceptional Net Margin

37%

Sustainable 3Y Average Net Margin

29%

Declining Net Margin

38% > 37%

Exceptional Free Cash Flow Margin

35%

Strong 3Y Average Free Cash Flow Margin

42%

Declining Free Cash Flow Margin

41% > 35%

Positive ROE

24%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

44%

Declining ROIC

72% > 57%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.